Vibrio cholerae (ATCC® 55860)

Strain Designations: Bah-3  /  Type Strain: no  /  Biosafety Level: 2

Classification Eltor biovar
Strain Designations Bah-3
Application
Transformation host
Produces the B, but not the A, subunit of cholera toxin
Used to produce attenuated vaccine strain against cholera
Enteric Research
Waterborne pathogen research
Isolation
Mutant derived from E7946-Sm, ATCC 55332
Potato, Solanum tuberosum, Hokkaido, Japan; 1993
Type Strain no
Biosafety Level 2
Antigenic Properties Serotype Ogawa (Mekalanos J. Genetically stable cholera vaccines with deletions of ctxA, recA and attRS1. US Patent 5,631,010 dated May 20 1997)
Preceptrol® no
Type Strain no
Antigenic Properties Serotype Ogawa (Mekalanos J. Genetically stable cholera vaccines with deletions of ctxA, recA and attRS1. US Patent 5,631,010 dated May 20 1997)
Antibiotic Resistance
Resistant to streptomycin
Comments
The ctxB gene is under control of the htp promoter.
Medium Medium 18: Trypticase Soy Agar/Broth
Growth Conditions
Temperature: 37.0°C
Atmosphere: Aerobic
Name of Depositor Harvard Medical School, JJ Mekalanos, Harvard Medical School
Isolation
Mutant derived from E7946-Sm, ATCC 55332
Potato, Solanum tuberosum, Hokkaido, Japan; 1993
References

Mekalanos J. Genetically stable cholera vaccines with deletions of ctxA, recA and attRS1. US Patent 5,631,010 dated May 20 1997

Mekalanos J. Genetically stable cholera vaccines with deletions of ctxA, recA and attRS1. US Patent 5,631,010 dated May 20 1997

Mekalanos J. Genetically stable cholera vaccines with deletions of ctxA, recA and attRS1. US Patent 5,631,010 dated May 20 1997